These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27351134)

  • 1. Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.
    Ronghe A; Chatterjee A; Bhat NK; Padhye S; Bhat HK
    Oncotarget; 2016 Aug; 7(32):51747-51762. PubMed ID: 27351134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.
    Ronghe A; Chatterjee A; Singh B; Dandawate P; Murphy L; Bhat NK; Padhye S; Bhat HK
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt B():500-12. PubMed ID: 25242450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant activities of novel resveratrol analogs in breast cancer.
    Chatterjee A; Ronghe A; Padhye SB; Spade DA; Bhat NK; Bhat HK
    J Biochem Mol Toxicol; 2018 Jan; 32(1):. PubMed ID: 28960787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.
    Ronghe A; Chatterjee A; Singh B; Dandawate P; Abdalla F; Bhat NK; Padhye S; Bhat HK
    Toxicol Appl Pharmacol; 2016 Jun; 301():1-13. PubMed ID: 26970359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
    Hatkevich T; Ramos J; Santos-Sanchez I; Patel YM
    Exp Cell Res; 2014 Oct; 327(2):331-9. PubMed ID: 24881818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells.
    Qi W; Sun M; Kong X; Li Y; Wang X; Lv S; Ding X; Gao S; Cun J; Cai C; Wang X; Chen J; Yin A; Yang Q
    Oncotarget; 2016 May; 7(18):26003-15. PubMed ID: 27027343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells.
    Yu X; Li R; Shi W; Jiang T; Wang Y; Li C; Qu X
    Biomed Pharmacother; 2016 Feb; 77():37-44. PubMed ID: 26796263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
    Kang Y; Cortina R; Perry RR
    J Natl Cancer Inst; 1996 Mar; 88(5):279-84. PubMed ID: 8614006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The synergistic inhibitory effect of 5-aza-2-deoxycytidine and Tamoxifen on estrogen receptor alpha negative breast cancer cell lines in vitro].
    Tang B; Peng ZH; Jiang J
    Zhonghua Wai Ke Za Zhi; 2005 Dec; 43(23):1545-9. PubMed ID: 16412295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
    Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC.
    Maqbool SN; Lim SC; Park KC; Hanif R; Richardson DR; Jansson PJ; Kovacevic Z
    Br J Pharmacol; 2020 May; 177(10):2365-2380. PubMed ID: 31975484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
    Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
    Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells.
    Berstein LM; Yue W; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):109-17. PubMed ID: 20683653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vitamin E on tamoxifen-treated breast cancer cells.
    Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
    Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitizing estrogen receptor-negative breast cancer cells to tamoxifen with OSU-03012, a novel celecoxib-derived phosphoinositide-dependent protein kinase-1/Akt signaling inhibitor.
    Weng SC; Kashida Y; Kulp SK; Wang D; Brueggemeier RW; Shapiro CL; Chen CS
    Mol Cancer Ther; 2008 Apr; 7(4):800-8. PubMed ID: 18413793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.
    Mai Z; Blackburn GL; Zhou JR
    Carcinogenesis; 2007 Jun; 28(6):1217-23. PubMed ID: 17234721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxycitric acid potentiates the cytotoxic effect of tamoxifen in MCF-7 breast cancer cells through inhibition of ATP citrate lyase.
    Ismail A; Doghish AS; E M Elsadek B; Salama SA; Mariee AD
    Steroids; 2020 Aug; 160():108656. PubMed ID: 32439410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.